New Approaches to Neuroblastoma Treatment (NANT) — Los Angeles, California

New Approaches to Neuroblastoma Treatment (NANT) is a clinical research site located in Los Angeles, California, United States 90027-6016.

Crixeo Health Trust Score: 46/100 (POOR). This profile has not yet been claimed by the site owner.

New Approaches to Neuroblastoma Treatment (NANT) has participated in 2 clinical trials.

Therapeutic areas: Disseminated Neuroblastoma, Recurrent Neuroblastoma.

Sponsors: National Cancer Institute (NCI).

Sponsor Feasibility Report

Trust Score: 46/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for New Approaches to Neuroblastoma Treatment (NANT)?

New Approaches to Neuroblastoma Treatment (NANT) has a Crixeo Trust Score of 46/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has New Approaches to Neuroblastoma Treatment (NANT) conducted?

New Approaches to Neuroblastoma Treatment (NANT) has 2 clinical trials on record. Their work covers Disseminated Neuroblastoma, Recurrent Neuroblastoma.

Is New Approaches to Neuroblastoma Treatment (NANT) accredited by Crixeo Health?

New Approaches to Neuroblastoma Treatment (NANT) has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about New Approaches to Neuroblastoma Treatment (NANT)?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.